Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
SBC Medical Group Holdings
NasdaqGM:SBC Community
3
Narratives
written by author
8
Comments
on narratives written by author
72
Fair Values set
on narratives written by author
Create a narrative
SBC Medical Group Holdings
Popular
Undervalued
Overvalued
SBC Medical Group Holdings
AL
Alpharum
Community Contributor
A New Addition to my 2025 Global Portfolio?
This Japanese-based company, SBC Medical Group Holdings Inc. (NASDAQ: SBC) is now making waves in the aesthetic healthcare market, offering a promising opportunity for investors in 2025.
View narrative
US$15.00
FV
69.6% undervalued
intrinsic discount
23.53%
Revenue growth p.a.
Set as Fair Value
13
users have liked this narrative
0
users have commented on this narrative
53
users have followed this narrative
3 months ago
author updated this narrative
SBC Medical Group Holdings
JO
johnsonpro
Community Contributor
Zacks' Valuation Could Lead to Significant Upside?
SBC Medical Group Holdings ( NASDAQ: SBC ) is making waves in the aesthetic medicine industry with its dynamic growth strategy and robust franchise model. Analysts at Zacks have set a target price of $11.00, reflecting confidence in SBC's ability to scale its operations and expand internationally.
View narrative
US$11.00
FV
58.5% undervalued
intrinsic discount
13.48%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
3 months ago
author updated this narrative
SBC Medical Group Holdings
MR
mrbensonv
Community Contributor
Hidden Gem (NASDAQ: SBC), Empowering the Growth of Aesthetic Medicine
Hidden Gem (NASDAQ: SBC), Empowering the Growth of Aesthetic Medicine SBC Medical Group Holdings ( NASDAQ: SBC ) is making waves in the aesthetic medicine industry with its dynamic growth strategy and robust franchise model. Analysts at Zacks have set a target price of $15.40, reflecting confidence in SBC's ability to scale its operations and expand internationally.
View narrative
US$4.64
FV
1.7% undervalued
intrinsic discount
4.98%
Revenue growth p.a.
Set as Fair Value
2
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
3 months ago
author updated this narrative
Your Valuation for
SBC
SBC Medical Group Holdings
Your Fair Value
US$
Current Price
US$4.56
47.1% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
288m
2015
2018
2021
2024
2025
2027
2030
Revenue US$287.7m
Earnings US$70.1m
Advanced
Set as Fair Value